Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × camrelizumab × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

INDUSTRY 5 OTHER 4 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 5 Gastrointestinal 5 Breast 2 Sarcoma 1 Other solid neoplasm 1 Dermatologic 1

Conditions

Interventions

pembrolizumab 2 fludarabine 2 apatinib 2 Interleukin-2 2 Cyclophosphamide 2 spartalizumab 1 phosphorylethanolamine 1 olaparib 1 liposomal doxorubicin 1 ivarmacitinib 1 camrelizumab 1 anlotinib 1 Valproic Acid 1 Topotecan 1 Talc 1 Pharmaceutical Services 1 Injections 1 Hydralazine 1 Cisplatin 1 Cerebral Decortication 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04832204 2021-04-05

Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases

Beijing Hospital

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡